APLNR and type 1 diabetes mellitus: In our study, we used a type 1 diabetes mouse model, and our results demonstrated that despite the presence of tissue ischemia, diabetes prevented the basal expression of APJ/apelin in the adductor muscle and lowered plasma apelin concentrations compared to nondiabetic mice.